Background: Assurance of prognostic elements is important for the management of renal cell carcinoma (RCC). Our goal was to check the relation between apparent diffusion coefficient (ADC) values and parameters predicting prognosis of RCC. Fifty pathologically confirmed RCC underwent diffusion-weighted (DW) MRI. ADC values were calculated using b factor (800 s/mm 2 ). The correlation between ADC values and tumor size, cystic/necrotic feature, growth pattern, unenhanced T1, histological grade, clinical stage, and distant metastasis were analyzed. Results: The optimal ADC threshold for prognosis of RCC appeared to be 1.4 × 10 −3 mm 2 /s. There was a significant inverse correlation between ADC values and growth pattern (R = − 0, P = 0.05), unenhanced T1(R = − 0.41, P = 0.01), cystic/necrotic feature (R = − 0.4, P = 0.01), histological grade (R = − 0.37, P = 0.02), clinical stage (r = − 0.4, P = 0.01), and distant metastasis (R = − 0.33, P = 0.04), and significant linear correlation with tumor size (R = 0.39, P < 0.02).
Background
Renal cell carcinoma (RCC) is a blended gathering of tumors that vary histologically with extensively differing prognosis [1] . It represents 2-3% of every single grownup malignant growth and is the sixth reason for death by tumor all through the world. Over 80% of renal tumors that emerge in the renal parenchyma are RCC, while most of renal pelvis malignancies are transitional cell carcinomas (TCCs) [2] . The three most basic subtypes of RCC are (i) clear-cell carcinoma, a standout among the most widely recognized sorts, representing 70-80% of cases; (ii) papillary renal cell carcinoma, representing about 10-15% of cases; and (iii) chromophobe renal carcinoma, which is the least normal, representing 5% of all RCCs [3] .
Prognostic factor is an element that can be utilized to evaluate the risk of disease recurrence, metastatic spread, and the clinical outcome. Guarantee of prognostic elements is fundamental for the management of RCC [4] .
Prognostic elements can be anatomical (tumor size and stage), histological (histological type and grade), clinical (performance status, local symptoms, and cachexia), and molecular factors [5] .
All of these features are not impeccably unique when handled alone. In this manner, an expanding number of prognostic systems or nomograms combining the independent prognostic factors have been developed. They were found to be more accurate using each factor alone [1] .
Diffusion-weighted imaging (DWI) may be justifiably different from computed tomography (CT) to outline renal masses, especially in patients with renal insufficiency. DWI was able to differentiate benign lesions from RCCs and allowed a non-contrast alternative for excluding malignancy [6] .
A few reports recommend that ADC might be related well with morphologic and histologic prognostic parameters in RCC [7] . Thus, the minimum ADC was observed to be an independent factor for recurrence of RCC after nephrectomy [8] . Yoshida et al. exhibited a measurably noteworthy distinction in the ADC between T1a RCC (estimate ≤ 4 cm) with or without lymph nodes or metastasis [9] . Therefore, we hypothesize that the ADC value may be one of the prognostic factors for tumor aggressiveness in patients with RCC. Therefore, we planned to estimate the ADC value as a prognostic factor for patients with RCC, as well as the correlation between the ADC value and other known prognostic parameters, including histopathological grade and clinical staging.
Methods

Patients
This retrospective research was approved by our institutional medical review board. Patient data were secured through coded files to ensure privacy and confidentiality. The study was conducted between February 2016 and September 2018.
We retrospectively collected and analyzed the MRI examinations of 50 patients with a histopathological diagnosis of RCC.
All lesions were confirmed at histopathologic examination after partial or total nephrectomy.
RCC was further divided into clear-cell carcinoma (n = 28), papillary carcinoma (n = 12), chromophobe carcinoma (n = 6), and non-classified carcinoma (n = 4).
Histopathological diagnosis and Fuhrman nuclear grading of the RCC served as the standard references for the statistical analysis.
The clinical stage follows the TNM staging system of the American Joint Committee on Cancer. This included 29 pathologically proven low-stage (I and II) lesions and 21 high-stage (III and IV) RCCs.
Imaging diagnosis was used to determine the preclinical stage. Imaging with ultrasound and plain chest radiographs were routinely acquired. Preoperative computed tomography and MRI was preoperatively performed. Metastasis was evaluated by other investigations including brain and bone scan if indicated.
MRI
All patients were scanned using 1.5 Tesla (Achieva 1.5 tesla SE-Philips) equipped with body phased-array coil. Magnevist (0.1 mmol/kg) was injected i.v at a rate of 1 ml/s followed by two-dimensional fast spoiled gradient contrast-enhanced sequences.
The protocol included respiratory-gated T2-weighted images and T2 fat-saturated sequence, pre-and post-contrast, breath-hold three-dimensional (3D) gradient fat-saturated T1-weighted sequence, breath-hold in-and out-of-phase sequence, and single-shot echo-planar diffusion-weighted sequence (DW) sequence using the following parameters: TR/TE: 8000/74-104 ms, slice thickness, 5 mm, interslice gap, 0 mm, FOV, 42-46, and matrix 128/128. b value of 800 s/mm 2 was used to calculate the ADC value. The ADC value was calculated by placing a region of interest (ROI) which was chosen to include solid components of the tumor and was set as large as possible. We quantified the ADC by physically applying a region of interest (ROI) to cover the solid parts of the tumor which was set in as broad an area as possible. Exceptional consideration was taken to maintain a strategic distance from necrotic, cystic, and hemorrhagic zones inside the tumors. In instances of tissues not showing diffusion restriction, the ROI was set in the most homogeneous part. These measurements were performed three times for each lesion and values were averaged to minimize measurement errors.
MRI evaluation
The MRI examination for all RCC was independently analyzed and then correlated with the pathology findings.
MRI images for renal masses were evaluated by one reviewer (MI) with 10 years of experience, who was blinded to the pathologic profile and clinical outcome and evaluated the images, including subtraction datasets.
The ADC was calculated by the software, where the signal intensity obtained at b = 800 s/mm 2 . The size of RCC lesions was calculated, and the greatest diameter was considered for statistical analysis.
All pathological data were analyzed using Fuhrman classification which assigns tumors with grades of I-IV [10] .
Tumor necrosis or cystic feature was defined as the area at the central location within the tumor, which shows high signal intensity on T2W images, low signal intensity on T1W images, and absence of enhancement.
The evaluation of a growth pattern was built on the largest axis of the tumor; cortical pattern was considered when RCC lesion was well defined without peripheral extension to the adjacent tissue whereas a tumor was classified as infiltrative if it had any degree of exophytic growth of tumor outside the expected contour of renal cortical parenchyma, as described previously [11, 12] .
Clinical stage
Distant metastasis was determined by abdominal and pelvic ultrasound examination, plain x-ray chest radiographs, and computed tomography. A radio-isotope scanning of the bone and brain or other investigation was only performed if indicated. A lymph node was considered positive if it had a maximum diameter larger than 1 cm with heterogeneity of enhancement or an irregular contour. Enlarged lymph nodes were not routinely and pathologically confirmed.
Statistical analysis
We summarized the data as mean ± standard deviation (continuous variables) or as percentages (categorical variables). Normal distribution of data was preliminarily verified by the Shapiro-Wilk test.
For statistical analysis, papillary carcinoma, chromophobe carcinoma, and non-classified carcinoma were considered as non-clear-cell carcinoma (n = 22), because of the small number of cases.
The relationship between ADC values and tumor size, tissue component (solid or mixed), unenhanced T1, growth pattern, histopathological diagnosis, histological grade, clinical stage, and distant metastasis were analyzed. Correlations between groups were assessed using Spearman's rank correlation analysis. Differences in the variables were evaluated by the Kruskal-Wallis test, Mann-Whitney's non-parametric test, or the χ 2 test. Probability values of P ≤ 0.05 were considered statistically significant. One way ANOVA analysis of variance was used to test the differences between more than two groups, followed by post hoc Tukey's test. If the test revealed a significant difference, receiver operating characteristic (ROC) analysis was performed to determine the area under the ROC curve and the optimal cutoff for the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of ADC values.
All statistical analyses were performed using SPSS® version 16.0 statistical software (SPSS Inc., Chicago, IL).
Results
Patients
Ultimately, 50 patients with 50 RCCs were included in the study. Of the 50 patients included in the study, 34 were females (68 %) and 16 were male (32 %) (see Table 1 ).
Histopathology revealed 28 (56 %) clear-cell carcinomas and 22 (44 %) non-clear carcinoma (including 12 (24 %) papillary renal cell carcinoma, 6 (12 %) chromophobe renal cell carcinoma, and 4 (8 %) unclassified carcinoma).
The histopathological grading was previewed as follows: 24 (48 %) grade 1, 5 (10 %) grade II, 16 (32 %) grade III, and 5 (10 %) grade IV lesions. The mean size of the RCC lesions was 6.1 cm (range 2-10 cm, SD ± 2.1 cm). Thirteen lesions (26 %) have size ≤ 4 cm, while 37 lesions (74 %) have size > 4 cm. Moreover, 26 (52.8%) lesions exhibit infiltrative growth (see Figs. 1 and 2) , and the presence of mixed tissue component (cystic/necrosis) was found in 16 (32 %) lesions (see Fig. 3 ).
Distant metastasis was found in 21(42 %) lesions. About 64.3 % of clear RCC patients have lymph node metastasis. Approximately 34 (68 %) lesions were solid while 16 (32 %) lesions were mixed.
All RCC had bright signal intensity on DW imaging, but, on unenhanced T1-weighted sequences, 33 RCC (66 %) were hypointense and 17 RCC (34%) were isointense. The distribution of ADC values by histopathological subtype can be seen in Fig. 4 .
Clear-cell RCC versus non-clear RCC
The comparison between the features of prognostic factors of clear and non-clear-cell RCC can be seen in Table 2 .
Among the various prognostic factors, growth pattern (P = 0.01), clinical stage (P < 0.05), distant metastasis (P < 0.05), and histological grade (P = 0.003) were significantly different.
Clear RCC had a mean ADC value of 1. /s). However, there was no evidence of statistically significant differences or correlation in between (P = 0.1 and r = 0.22, P = 0.13) ( Table 3) .
The performance of ADC for differentiating clear RCC from non-clear RCC is shown in Fig. 5 . Selection of 1.4 × 10 −3 mm 2 /s as a cutoff point of ADC value revealed an area under curve (AUC) of 0.62, sensitivity of 53.6%, and specificity of 72.7 %.
Relation between ADC and prognostic factors
The relations between mean ADC values and prognostic factors are shown in Table 3 . The ADC values between groups were non-normally distributed. The mean of Table 3 ).
Prognostic factors associated with low ADC values (≤ 1.4 × 10 −3 mm 2 /s ) were male gender, tumor size ≤ 4 cm, iso T1 signal intensity, solid lesions, infiltrative growth pattern, cystic/necrotic features, distant metastasis, grade IV, and high-stage (III and IV) RCCs Figs. (1, 3, and 2 ).
Prognostic factors with statistically significant positive correlation were gender (r = 0.28, P = 0.05) and tumor size (r = 0.48, P < 0.05).
Prognostic factors with statistically significant negative correlation were cystic/necrotic feature (r = − 0.4, P = 0.004), growth pattern (r = − 0.3, P = 0.01), clinical stage (r = − 0.4, P = 0.01), distant metastasis (r = − 0.4, P = 0.01), histological grade (r = − 0.4, P = 0.004), and unenhanced T1 (r = − 0.5, P = 0.001).
The performance of ADC for differentiating low-stage from high-stage RCC is shown in Fig. 6 . Selection of 1.2 × 10 −3 mm 2 /s as a cutoff point of ADC value revealed an AUC of 0.6, sensitivity of 42.9 %, and specificity of 100 %.
Discussion
In the present study, estimation of ADC value of RCC was significantly correlated with gender, tumor size, A b value of 800 s/mm 2 was used in the current study because we had relatively few cases for histopathological /s) [18] . There is no doubt that evaluation of ADC value depends mainly on the number of cells and the relatively intercellular space which in turn can restrict water movement. Clear RCC tumors are characterized by narrow intercellular space due to presence of large cell and rich cytoplasm, in contrast to non-clear RCC. In the results of Paudyal, although different in appearance, the ADC values 
largely agreed, and this could be due to the size of samples taken and the nature of the tumors. So, further studies with larger patient populations are warranted [18] . The number of cells is a crucial indicator of tumor grade [19] . It has been suggested that the decreased ADC value may be due to their increased cellularity, larger nuclei with more abundant macromolecular proteins, and less extracellular space [20, 21] .
The present study demonstrated a significant inverse relationship between ADC values and histological grade. On another side, in a study including 57 patients, Rosenkrantz et al. revealed a strong positive correlation of the ADC to grading [22] . Yu et al. reported that there were statistically significant differences in the ADC values of low-and high-grade RCCs [20] . Conversely, Sandrasegaran et al. observed no significant difference in ADC values related to tumor grading [23] .
Heterogeneity of RCC may explain this contradictory data, because some tumor presents areas of different grades, which are often found within the same tumor. Therefore, Gurel et al. [24] suggested that conventional MRI in addition with ADC was superior to percutaneous biopsy and might improve tissue characterization.
In the current study, there was a statistically significant difference in ADC values between low and high-stage RCCs. RCC accompanied by significantly low ADC values ≤ 1.2 × 10 −3 mm 2 /s is related to the presence of distant metastasis. Our result agreed with the previous study, which found a statistically significant difference in the ADC [26] .
In the general role, the size of RCC may not have a role in the determination of RCC aggressiveness but has a role in predicting the nuclear grade of RCC. So, ADC values should be used in conjunction with tumor size as an additional finding.
In the current study, RCC lesion with distant metastasis had statistically significant lower mean ADC values with strong negative correlation. A previous study reported that ADC values of clear RCC may be related to the presence of distant metastasis. Thus, in a clinical situation, clear-cell RCC with low ADC values should be inspected broadly for the risk of distant metastasis [26] .
In our study, we have defined growth pattern as a parameter and analyzed its prognostic usefulness. The infiltrative lesion had low ADC value compared to cortical lesion, in addition to the strong positive correlation noted in between.
Recently, few reports considered that RCC with an infiltrative growth pattern may have more migration capacity than RCC with cortical growth pattern and adopted growth pattern as a parameters for RCC prognosis [27] . Further studies are crucial to approve the convenience of this parameter.
The presence of tumor necrosis is a well-established independent indicator of a poor prognosis for RCC, and presence of necrosis results in higher ADC values [18, 19] . In our study, there was a statistically significant positive correlation between the ADC values and tumor necrosis.
We found a strong negative correlation between ADC values and the tissue component. The solid lesions had statistically significantly lower mean ADC value levels than cystic/necrotic lesions.
The histology of RCC is heterogeneous and contains a lot of variety including necrosis, hemorrhage, debris, and solid tissues which elevate the value of ADC [1] .
In our study, T1 isointense lesions were associated with lower ADC values, and there was a strong negative correlation between ADC values and T1 signal intensity. This result was seen in previously published data [28] . This compatibility might be a result of the homogeneity of the different lesions and the comparison between the same malignant group. This study has several limitations. Firstly, the study had a retrospective, non-randomized design and single institutional series. Secondly, only one b value (800 mm 2 /s) was used for the estimation of the ADC. It may be fascinating to get additional b values to obtain more strict ADC data. Thirdly, we did not estimate the reproducibility of the ADC values gathered for RCC.
Conclusion
In conclusion, evaluation of ADC value of RCC was significantly correlated with gender, tumor size, cystic/necrotic features, growth pattern, clinical stage, distant metastasis, 
